Health News

FDA Committee Backs Heart Arrhythmia Drug
In a what came as a surprise move to many, the U.S. Food and Drug Administration advisory committee today voted to recommend heart arrhythmia drug rivaroxiban (Xarelto) for approval.
America is Up In Smokes
Tobacco use is the most preventable cause of death in the United States, yet so many Americans choose to continue day after day. The rates are slowly declining, but by how much?
Aging Heart Attacks
Menopause and its hormonal changes can cause many symptoms including hot flashes, sleeplessness and night sweats. Menopause isn't causal, however in heart attacks.
Stroke Risk Rising for Young Adults
American adults have gotten heavier and a sizeable percentage don't live a healthy lifestyle. Young adults and teens seem to be following in those same footsteps.
Stroke or Death Risk Increased with Brain Stent
Patients who receive brain stents after a stroke have a much higher chance of suffering another stroke or dying. Receiving aggressive medical therapy was found to be more than twice as effective.
FDA Panel Warns Against Approval of Heart Arrhythmia Drug
U.S. Food and Drug Administration reviewers have warned against immediate approval of rivaroxaban (Xarelto) and questioned effectiveness of the medication for preventing stroke in high-risk atrial fibrillation patients.
Back Pain Weighing You Down
Extra weight might not seem like a lot of trouble, but the more weight you add on the more pain you might feel - especially in your lower back. Lose the weight to feel physically better.
Reducing Muscle Damage After a Heart Attack
It had been suggested there was a way to reduce the amount of heart muscle damage after a heart attack. New research shows the method that had been believed to help does not cut muscle damage.
Heart Disease is in Your DNA
Both genetics and lifestyle play a part in developing coronary heart disease. It's long been debated which plays the larger role. A new study suggests it may be the genes.
What's The Benefit From Lengthier CPR
Standards for the length of time cardiopulmonary resuscitation should be performed vary, though recent research had suggested a longer period of up to three minutes could be beneficial.